Inicio/Acciones/LXRX

LXRX

USD

Lexicon Pharmaceuticals Inc. Common Stock

$1.340+0.010 (0.752%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.330

Máximo

$1.390

Mínimo

$1.325

Volumen

2.72M

Fundamentos de la Empresa

Capitalización de Mercado

487.0M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

2.36M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.28Actual $1.340Máximo $1.66

Noticias Relacionadas

4 nov 2025 · 13:30

GlobeNewswire

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans

THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that data from three studies of sotagliflozin will be presented during upcoming medical meetings. Two

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans

30 oct 2025 · 12:30

GlobeNewswire

Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior